Roberts J.A.; Pea F.; Lipman J., The clinical relevance of plasma protein binding changes, «CLINICAL PHARMACOKINETICS», 2013, 52, pp. 1 - 8 [articolo]
Cataldo M.A.; Tacconelli E.; Grilli E.; Pea F.; Petrosillo N., Continuous versus intermittent infusion of vancomycin for the treatment of gram-positive infections: Systematic review and meta-analysis, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2012, 67, pp. 17 - 24 [articolo]
F. Pea;P. Viale;P. Cojutti;M. Furlanut, Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2012, 56, pp. 6343 - 6348 [articolo]
Pea F.; Cojutti P.; Dose L.; Furian C.; Guarrera G.; Furlanut M., Personalization of antimicrobial dosing regimens: Indicators of performance, «ITALIAN JOURNAL OF PUBLIC HEALTH», 2012, 9, pp. 1 - 5 [articolo]
Pea F, Pharmacokinetics in everyday clinical practice, ITA, SEEd Edizioni Scientifiche, 2012, pp. 112 . [libro]
Falcone M.; Blasi F.; Menichetti F.; Pea F.; Violi F., Pneumonia in frail older patients: An up to date, «INTERNAL AND EMERGENCY MEDICINE», 2012, 7, pp. 415 - 424 [articolo]
Pea F; Cojutti P; Pagotto A; Cristini F; Furlanut M; Viale P, Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy., «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2012, 56, pp. 3438 - 3440 [articolo]
Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M, Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients., «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2012, 67, pp. 2034 - 2042 [articolo]
Pea, Federico; Cojutti, Piergiorgio; Petrosillo, Nicola; Furlanut, Mario; Entenza, J M; Veloso, T R; Vouillamoz, J; Giddey, M; Moreillon, P, Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2011, 55, pp. 4496 - 4497 [replica/breve intervento]
Pea F; Mazzei T, Farmaci antifungini, in: Farmacologia - Principi di base ed applicazioni terapeutiche, Milano, Edizioni Minerva Medica, 2011, pp. 708 - 720 [commento giuridico]
Tavio M.; Grossi P.; Baccarani U.; Scudeller L.; Pea F.; Berretta M.; Adani G.; Vivarelli M.; Riva A.; Tirelli U.; Bresadola V.; Viale P.; Risaliti A., HIV-infected patients and liver transplantation: Who, when and why, «CURRENT HIV RESEARCH», 2011, 9, pp. 120 - 127 [articolo]
Grossi PA; Gasperina DD; Barchiesi F; Biancofiore G; Carafiello G; De Gasperi A; Sganga G; Menichetti F; Montagna MT; Pea F; Venditti M; Viale P; Viscoli C; Nanni Costa A, Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients., «TRANSPLANTATION PROCEEDINGS», 2011, 43, pp. 2463 - 2471 [articolo]
Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P, Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases., «TRANSPLANTATION PROCEEDINGS», 2011, 43, pp. 1119 - 1122 [articolo]
Pea F.; Cojutti P.; Sbrojavacca R.; Cadeo B.; Cristini F.; Bulfoni A.; Furlanut M., TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient, «THE ANNALS OF PHARMACOTHERAPY», 2011, 45, pp. e37 - 1022 [articolo]
Cataldo M.A.; Tacconelli E.; Pea F.; Petrosillo N., Vancomycin way of administration: Where is the evidence?, «CLINICAL INFECTIOUS DISEASES», 2011, 53, pp. 308 - 310 [replica/breve intervento]
